Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01EWH
|
|||
Drug Name |
Quinolinyl compound 1
|
|||
Synonyms |
PMID25828189-Compound-23
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
PFIZER INC. DIDIUK, Mary FILIPSKI, Kevin J. GUZMAN-PEREZ, Angel LEE, Esther C. PFEFFERKORN, Jeffrey A. STEVENS, Benjamin TU, Meihua
|
|||
Structure |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Glucagon receptor (GCGR) | Target Info | Antagonist | [1] |
Target's Patent Info | Glucagon receptor (GCGR) | Target's Patent Info | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Glucagon signaling pathway | ||||
Reactome | Glucagon signaling in metabolic regulation | |||
G alpha (q) signalling events | ||||
G alpha (s) signalling events | ||||
Glucagon-type ligand receptors | ||||
WikiPathways | GPCRs, Class B Secretin-like | |||
Gastrin-CREB signalling pathway via PKC and MAPK | ||||
Integration of energy metabolism | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Small molecule glucagon receptor antagonists: a patent review (2011 - 2014).Expert Opin Ther Pat. 2015 Jul;25(7):819-30. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.